Next Article in Journal
A Food, a Bite, a Sip: How Much Allergen Is in That?
Next Article in Special Issue
Creatine Supplementation in Children and Adolescents
Previous Article in Journal
Association between Depression, Lifestyles, Sleep Quality, and Sense of Coherence in a Population with Cardiovascular Risk
Previous Article in Special Issue
Potential of Creatine in Glucose Management and Diabetes
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:

Creatine Supplementation and Brain Health

Applied Physiology & Nutrition Research Group, Rheumatology Division, School of Physical Education and Sport, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo 01246-903, Brazil
Food Research Center, University of São Paulo, Sao Paulo 05508-080, Brazil
FSPE Applied Bioenergetics Lab, University of Novi Sad, 21000 Novi Sad, Serbia
Department of Health, Nutrition, and Exercise Science, Messiah University, Mechanicsburg, PA 17055, USA
Author to whom correspondence should be addressed.
Nutrients 2021, 13(2), 586;
Submission received: 18 January 2021 / Revised: 3 February 2021 / Accepted: 4 February 2021 / Published: 10 February 2021
(This article belongs to the Special Issue Creatine Supplementation for Health and Clinical Diseases)


There is a robust and compelling body of evidence supporting the ergogenic and therapeutic role of creatine supplementation in muscle. Beyond these well-described effects and mechanisms, there is literature to suggest that creatine may also be beneficial to brain health (e.g., cognitive processing, brain function, and recovery from trauma). This is a growing field of research, and the purpose of this short review is to provide an update on the effects of creatine supplementation on brain health in humans. There is a potential for creatine supplementation to improve cognitive processing, especially in conditions characterized by brain creatine deficits, which could be induced by acute stressors (e.g., exercise, sleep deprivation) or chronic, pathologic conditions (e.g., creatine synthesis enzyme deficiencies, mild traumatic brain injury, aging, Alzheimer’s disease, depression). Despite this, the optimal creatine protocol able to increase brain creatine levels is still to be determined. Similarly, supplementation studies concomitantly assessing brain creatine and cognitive function are needed. Collectively, data available are promising and future research in the area is warranted.

1. Introduction

The ergogenic effects of creatine supplementation are well documented, with evidence supporting its efficacy in increasing muscle strength, lean mass, and exercise performance/muscle function, particularly when combined with exercise in different populations, from athletes to a wide spectrum of patient populations [1,2,3].
Creatine mechanisms of action involve rapid energy provision by transferring the N-phosphoryl group from phosphorylcreatine (PCr) to adenosine diphosphate (ADP), thus resynthesizing adenosine triphosphate (ATP) and spatial energy buffering, transferring energy from the mitochondria to the cytosol. These mechanisms are responsible for facilitating ATP homeostasis during high energy turnover, maintaining a low ADP concentration and reducing Ca2+ leakage from the sarcoplasmic reticulum and impairment of force output of the muscle [4,5,6]. Additionally, creatine could also attenuate the formation of reactive oxygen species by its coupling with ATP into the mitochondria or by scavenging radical species in an acellular setting [7]. Its direct and indirect antioxidant effects have been suggested to have therapeutic effects in neurodegenerative diseases [8].
Although most of the total body’s creatine is found in skeletal muscle, the brain is also a very metabolically active tissue, accounting for up to 20% of the body’s energy consumption [9,10]. Creatine kinase (CK), a main enzyme involved in the ATP/CK/PCr system, is also expressed in a brain-specific isoform (BB-CK) [4,5,6], suggesting that creatine may also be relevant for energy provision to the central nervous system (CNS). In fact, creatine-deficient syndromes involving brain creatine depletion are characterized by major mental and developmental disorders (e.g., mental retardation, learning delays, autism, and seizures), which may be partially reversed by creatine supplementation [11,12,13,14]. Cognitive processing may also be affected by creatine metabolism, as it may facilitate ATP homeostasis during periods of rapid or altered brain ATP turnover, such as during complex cognitive tasks, hypoxia, sleep deprivation, and some neurological conditions [3,15,16]. Additionally, creatine supplementation might be beneficial for mild traumatic brain injury (mTBI), which is also associated with changes in brain energy needs. The effects of creatine supplementation on brain creatine levels, cognitive processing, and mTBI have been previously reviewed [3,17,18]. As this is a growing field, the purpose of this short review is to provide an update regarding the effects of creatine supplementation on brain health in humans beyond what is discussed in Dolan et al. [3].

2. The Effects of Creatine Supplementation on Brain Creatine Levels

While muscle exclusively relies on dietary ingestion and endogenous synthesis from the liver, kidneys, and pancreas [19], the brain can synthesize creatine. The enzymatic apparatus necessary for endogenous creatine synthesis is found in the nervous system and creatine transporters are found at the blood–brain barrier, neurons and oligodendrocytes cells, indicating that brain creatine may not solely dependent on endogenous production from other organs or dietary sources [20]. Furthermore, brain creatine seems not to be influenced by habitual dietary intake from food, as similar brain PCr is found between vegetarians and omnivores [21]. Still, if the intracerebral synthesis is limited due to inherited disorders of creatine-catalyzing enzyme(s) machinery, dietary provision of the compound can positively affect brain creatine concentrations [22]. Figure 1 illustrates endogenous creatine synthesis in the brain and its transport across the blood–brain barrier.
Brain creatine content has been suggested to be affected by other factors, such as aging [23]; however, comparable levels of brain PCr have also been found between apparently healthy elderly and young individuals [24]. Other factors related to aging that may influence brain creatine concentrations include reduced brain and/or physical activity, depression, schizophrenia, and panic disorder. The overlap between these factors may be misleading as to what might be identified as an age-related decline (reviewed in Rawson and Venezia [25]).
While consistent information is available on supplementation protocols aimed at increasing muscle creatine content [26], much less is known regarding the optimal supplementation strategy to increase brain creatine levels. A large heterogeneity in respect to brain creatine assessment technique (i.e., total brain creatine as assessed by H1-NMR vs. brain PCr as assessed by P31-NMR), supplement dose and duration (range 2 to 20 g/d for 1 to 8 weeks), and population characteristics (including habitual dietary creatine intake, health status, etc.) hampers direct comparison between the few studies on the topic. Further confusion is introduced by the fact that creatine content may differ regionally within the brain [25,27]. Nevertheless, collectively, the available literature suggests possible increases in both creatine and PCr in the brain following supplementation, though smaller than that seen in muscle (~half the increase) [3]. As reviewed in detail by Dolan et al. [3], there are currently 12 studies of the effects of creatine supplementation on brain creatine or PCr concentrations. Nine of these studies showed a significant increase in brain creatine, averaging about 5 to 10%, which is less than the increase in muscle creatine or PCr resulting from similar supplementation protocols. Some of these studies focused on patient populations who have altered brain energetics, including females with major depressive disorder, depression and amphetamine use, and selective serotonin uptake inhibitor resistant depression. Other groups investigated the effects of creatine ingestion on brain creatine levels in apparently healthy individuals. There is no clear indication why a small number of studies were ineffective at increasing brain creatine despite using similar supplementation protocols, but differences in baseline brain creatine levels, brain creatine assessment, population characteristics, and dosing strategies likely play a role.
The explanation for these differences in creatine uptake between muscle and brain remains speculative. As discussed, brain creatine content may rely less on exogenous creatine than muscle [20,21,24,28], which could theoretically involve a down-regulated response in brain creatine synthesis upon supplementation. Alternative to this hypothesis is the demonstration that the brain lacks the expression of creatine transporter in the astrocytes involved in the blood–brain barrier, thus implying a limited permeability of the brain to the circulating creatine [29], which is in line with the lack of increase in brain creatine following supplementation reported by some studies [24,28,30]. It is also plausible to speculate that if the brain is, in fact, resistant to exogenous creatine, a high-dose, long duration protocol would be needed, such as those used in the study by Dechent et al. [27] (i.e., 20 g/day for 4 weeks). The need for a higher supplementation dose in order to increase brain creatine level, as compared to the supplementation dose required for muscle, is further corroborated by data available from the only study assessing both muscle and brain creatine levels in response to supplementation, with increases found in the former, but not the latter [24]. Of interest, supplementing guanidinoacetic acid (GAA), a creatine precursor, was found superior to an equimolar dose of creatine in increasing brain creatine content [31]. While creatine is mainly transported via a specific transporter (SLC6A8 or CT1; also used for GAA transport), dietary GAA could be imported to the brain through additional delivery transporters and routes (including SLC6A6, GAT2, and passive diffusion) [32] and become readily available for methylation to creatine. Although preliminary, these data are of relevance considering the inherent capacity of the brain to synthesize creatine and its theoretical impaired ability to transport creatine through the blood–brain barrier, thus warranting further research on alternative strategies to increase brain creatine.

3. Creatine Supplementation and Cognition

The interest in the effects of creatine supplementation on cognition is not new. Despite the number of positive studies available on the subject (Summarized in Table 1), differences between investigations including study populations, cognitive function testing, and supplementation dosing and duration precludes direct comparison; however, some conclusions can be made. Although controversial [28,33,34], creatine supplementation may positively influence some aspects of cognition in different experimental paradigms [10,35,36,37,38,39,40]. Importantly, its effects seem more pronounced in stressful conditions such as hypoxia [8] and sleep deprivation combined with exercise [10,37,38]. Despite the suggestion that more complex or demanding cognitive processes are more prone to respond to supplementation (as they are more energy demanding), inconsistencies regarding cognitive test response to supplementation hampers further conclusions [37,38]), which may be attributed to differences in experimental design such as the sleep deprivation period and exercise intensity employed between studies.
In elderly individuals, specifically, literature is conflicting on the effects of creatine supplementation on cognitive performance. While McMorris et al. [16] showed improved cognitive performance, Alves et al. [33] found creatine (alone or associated with exercise training) ineffective. Both studies are limited by the lack of brain creatine concentration assessments, casting doubt on whether aging-related reduction in cognitive processing may arise from the presence of, for instance, neurodegenerative diseases or whether the supplementation protocol employed (designed for increasing muscle creatine content) may have been insufficient to significantly increase brain PCr. Recently, Smolarek et al. [43] found increased cognitive performance (and handgrip strength) after a 16 week intervention combining resistance training and creatine supplementation (5 g/day) in a pilot study including older adults. The results are, however, limited by the absence of an exercising control group and inconsistent cognitive performance in the control group across time, thus hampering further conclusion on the effects of supplementation alone.
It has been contended that vegetarians may differentially respond to creatine supplementation when compared to meat-eaters. In this respect, cognitive function has been shown to be improved in vegetarians after creatine supplementation [39]. Another study found greater effects on memory in vegetarians as compared to omnivores following creatine supplementation [15]. Importantly, the lack of a control group (meat-eaters) and the fact that between-group differences were due to decreased performance in the omnivores, rather than an improvement in the vegetarians, limits the conclusions of this study. Additionally, comparable brain creatine concentrations have been shown between meat-eaters and vegetarians [21], which undermines the theory that vegetarians should respond better than meat-eaters due to lower pre-supplementation brain creatine. More research should be conducted on the differential responses to creatine supplementation between vegetarians and omnivores.
Improvements in cognitive processing capability is also of interest to athletes. Several sports include motor control, decision making, coordination, reaction time, and other cognitive tasks as key aspects of performance, which may be affected by mental fatigue [45]. In this respect, creatine may play an ergogenic role, as, theoretically, it may mitigate mental fatigue, thus favouring performance. Indeed, creatine has been shown effective in attenuating the effects of sleep deprivation on throwing accuracy in rugby players [42], while no effect was observed on passing accuracy in non-stressed soccer players [46,47]. Brain creatine content was not assessed in these studies, raising uncertainty as to whether the results observed result from changes in brain creatine. Nonetheless, the discrepancy in the results may, at least partially, relate to the suggestion that creatine supplementation is most effective under stressed cognitive processes conditions such as sleep deprivation.
More recently, two studies revisited the subject, with interesting results. Borchio et al. [41] found improved performance in selected indexes of cognitive function after a time-trial track test in semi-professional mountain bikers supplemented with creatine. Interestingly, no prior cognitive deficit-inducing condition, such as sleep deprivation, was imposed, suggesting that creatine could potentially attenuate mental fatigue even in non-stressed situations. Van Cutsem et al. [44] studied the effects of creatine supplementation on mental fatigue and its negative effects on psychomotor skills in a non-athlete population and found that creatine was able to improve Stroop accuracy during a 90 min Stroop task and to increase strength endurance (assessed by a handgrip strength test) pre-to-post Stroop task. Importantly, no effects of supplementation were observed on the mental-fatigue-induced impairments in psychomotor and cognitive performance. Collectively, although these results suggest a potential role of creatine on mental fatigue, whether and to what extent this could affect specific sports performance remains to be elucidated.

4. Creatine Supplementation and Brain Injury, Concussion, and Hypoxia

One of the characteristics of traumatic brain injury is the alteration of ATP demand due to reduced blood flow and hypoxia [48]. Importantly, brain creatine is reduced following a mild traumatic brain injury (mTBI) [49], making creatine supplementation, and subsequent increase in brain creatine, a potentially valuable strategy to reduce severity of, or enhance recovery from, mTBI or concussion by offsetting negative changes in energy status. The duration of the dysregulation in brain energy metabolism is not clearly defined, but could remain for weeks if not years. Alosco et al. [50] reported on retired players from the National Football League (aged 40 to 69) who had experienced repetitive head impacts during their career and many years later had complaints of cognitive and/or behavioral/mood symptoms. In this cohort, there was a relationship between greater exposure to repetitive head impacts and decreased brain creatine in the parietal white matter. This indicates that there could be later-life derangements in brain energy metabolism subsequent to mTBI, and lends support to the concept that creatine supplementation could be valuable in enhancing recovery from mTBI, even years after the injury. In addition to its potential role in aiding the cellular energy crisis induced by injury, creatine may lessen other features of mTBI, such as membrane disruption leading to calcium influx, nerve damage, mitochondrial dysfunction, oxidative stress, and inflammation (reviewed in [48,51]).
In an experimental model mimicking the effects of mTBI, Turner et al. [10] found that supplementation was able to increase brain creatine and cognitive processing during oxygen deprivation. Animal models have also been employed to investigate the effects of creatine supplementation on traumatic brain injury. Sullivan et al. [52] found significant reduction in brain damage following traumatic brain injury in both mice (36%) and rats (50%). These large effects are compelling, but as humans only increase brain creatine about 10% in response to supplementation and some animals increase brain creatine 30 to 50%, it is difficult to generalize these data to the general population or athletes [53]. Despite its potential, experimental data in humans are still scarce; however, results from the few studies available are promising. Creatine supplementation has been shown able to improve cognition, communication, self-care, personality, and behavior, and reductions in headaches, dizziness, and fatigue in children with mTBI [54,55].
Collectively, despite limited data, creatine supplementation seems potentially beneficial in reducing severity of or enhancing recovery from mTBI, warranting further studies on its role not only as a post-injury therapy but also as a neuroprotective agent in populations at high risk of mTBI. As has been described elsewhere, creatine supplements have documented muscular performance benefits, are inexpensive, widely available, and have a strong safety profile [26,56,57,58,59,60,61,62,63]. Encouraging supplementation to reduce damage from or enhance recovery from mTBI based primarily on animal and theoretical data in lieu of clinical trials would ordinarily be considered premature. However, in this instance, given the devastating effects of mTBI, combined with the large body of safety and efficacy creatine supplementation data, encouraging supplementation for populations who are at high risk for mTBI might be considered more prudent.

5. Conclusions and Future Directions

There is a potential for creatine supplementation to improve cognitive processing, especially in conditions characterized by brain creatine deficits, which could be induced by acute stressors (e.g., exercise, sleep deprivation) or chronic, pathologic conditions (e.g., creatine synthesis enzyme deficiencies, mTBI, aging, Alzheimer’s disease, depression).
However, at least three main gaps remain. First, it is important to determine the optimal creatine protocol able to increase brain creatine levels. So far, dose-response studies are lacking and protocols are heterogenous. Second, supplementation studies concomitantly assessing brain creatine levels and cognitive function are needed, as it may help establish causation for the effect of creatine supplementation on cognition. Third, the identification of novel conditions in which creatine supplementation may be more effective in improving cognitive function is warranted as creatine in a rested healthy brain has been shown to have a lessened effect.

Author Contributions

Conceptualization, H.R., B.G., S.M.O. and E.S.R.; writing—review and editing, H.R., B.G., S.M.O., E.S.R. All authors have read and agreed to the published version of the manuscript.


This research received no external funding.


The authors would like to thank all of the research participants, scholars, and funding agencies who have contributed to the research cited in this manuscript. The figure was created with

Conflicts of Interest

B.G. has received research grants, creatine donation for scientific studies, travel support for participation in scientific conferences and honorarium for speaking at lectures from AlzChem (a company which manufactures creatine). Additionally, he serves as a member of the Scientific Advisory Board for Alzchem. E.S.R. has conducted industry-sponsored research on creatine and received financial support for presenting on creatine at industry-sponsored scientific conferences. Additionally, he serves as a member of the Scientific Advisory Board for AlzChem, who sponsored this special issue. S.M.O. serves as a member of the Scientific Advisory Board on creatine in health and medicine (AlzChem LLC). S.M.O. owns patent “Sports Supplements Based on Liquid Creatine” at the European Patent Office (WO2019150323 A1), and active patent application “Synergistic Creatine” at the UK Intellectual Property Office (GB2012773.4). S.M.O. has served as a speaker at Abbott Nutrition, a consultant of Allied Beverages Adriatic and IMLEK, and an advisory board member for the University of Novi Sad School of Medicine, and has received research funding related to creatine from the Serbian Ministry of Education, Science, and Technological Development, Provincial Secretariat for Higher Education and Scientific Research, AlzChem GmbH, KW Pfannenschmidt GmbH, and ThermoLife International LLC. S.M.O. is an employee of the University of Novi Sad and does not own stocks and shares in any organization.


  1. Gualano, B.; Roschel, H.; Lancha, A.H.; Brightbill, C.E.; Rawson, E.S.; Junior, A.H.L. In sickness and in health: The widespread application of creatine supplementation. Amino Acids 2011, 43, 519–529. [Google Scholar] [CrossRef]
  2. Dolan, E.; Artioli, G.G.; Pereira, R.M.R.; Gualano, B. Muscular Atrophy and Sarcopenia in the Elderly: Is There a Role for Creatine Supplementation? Biomolecules 2019, 9, 642. [Google Scholar] [CrossRef] [Green Version]
  3. Dolan, E.; Gualano, B.; Rawson, E.S. Beyond muscle: The effects of creatine supplementation on brain creatine, cognitive processing, and traumatic brain injury. Eur. J. Sport Sci. 2019, 19, 1–14. [Google Scholar] [CrossRef]
  4. Wallimann, T.; Wyss, M.; Brdiczka, D.; Nicolay, K.; Eppenberger, H.M. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: The ‘phosphocreatine circuit’ for cellular energy homeostasis. Biochem. J. 1992, 281, 21–40. [Google Scholar] [CrossRef] [Green Version]
  5. Wallimann, T.; Turner, D.C.; Eppenberger, H.M. Localization of creatine kinase isoenzymes in myofibrils. I. Chicken skeletal muscle. J. Cell Biol. 1977, 75, 297–317. [Google Scholar] [CrossRef] [Green Version]
  6. Sahlin, K.; Harris, R.C. The creatine kinase reaction: A simple reaction with functional complexity. Amino Acids 2011, 40, 1363–1367. [Google Scholar] [CrossRef]
  7. Sestili, P.; Martinelli, C.; Colombo, E.; Barbieri, E.; Potenza, L.; Sartini, S.; Fimognari, C. Creatine as an antioxidant. Amino Acids 2011, 40, 1385–1396. [Google Scholar] [CrossRef] [PubMed]
  8. Beal, M.F. Neuroprotective effects of creatine. Amino Acids 2011, 40, 1305–1313. [Google Scholar] [CrossRef]
  9. Gualano, B.; Artioli, G.G.; Poortmans, J.R.; Junior, A.H.L. Exploring the therapeutic role of creatine supplementation. Amino Acids 2009, 38, 31–44. [Google Scholar] [CrossRef] [PubMed]
  10. Turner, C.E.; Byblow, W.D.; Gant, N. Creatine Supplementation Enhances Corticomotor Excitability and Cognitive Performance during Oxygen Deprivation. J. Neurosci. 2015, 35, 1773–1780. [Google Scholar] [CrossRef] [PubMed]
  11. Kaldis, P.; Hemmer, W.; Zanolla, E.; Holtzman, D.; Wallimann, T. ’Hot Spots’ of Creatine Kinase Localization in Brain: Cerebellum, Hippocampus and Choroid Plexus. Dev. Neurosci. 1996, 18, 542–554. [Google Scholar] [CrossRef] [PubMed]
  12. Salomons, G.S.; Van Dooren, S.J.M.; Verhoeven, N.M.; Marsden, D.; Schwartz, C.; Cecil, K.M.; Degrauw, T.J.; Jakobs, C. X-linked creatine transporter defect: An overview. J. Inherit. Metab. Dis. 2003, 26, 309–318. [Google Scholar] [CrossRef]
  13. Stockler, S.; Holzbach, U.; Hanefeld, F.; Marquardt, I.; Helms, G.; Requart, M.; Hanicke, W.; Frahm, J. Creatine Deficiency in the Brain: A New, Treatable Inborn Error of Metabolism. Pediatr. Res. 1994, 36, 409–413. [Google Scholar] [CrossRef]
  14. Stockler, S.; Schutz, P.W.; Salomons, G.S. Cerebral creatine deficiency syndromes: Clinical aspects, treatment and pathophysiology. Alzheimer’s Dis. 2007, 46, 149–166. [Google Scholar] [CrossRef]
  15. Benton, D.; Donohoe, R. The influence of creatine supplementation on the cognitive functioning of vegetarians and omnivores. Br. J. Nutr. 2010, 105, 1100–1105. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. McMorris, T.; Mielcarz, G.; Harris, R.C.; Swain, J.P.; Howard, A.N. Creatine Supplementation and Cognitive Performance in Elderly Individuals. Aging Neuropsychol. Cogn. 2007, 14, 517–528. [Google Scholar] [CrossRef] [PubMed]
  17. Rae, C.D.; Bröer, S. Creatine as a booster for human brain function. How might it work? Neurochem. Int. 2015, 89, 249–259. [Google Scholar] [CrossRef] [PubMed]
  18. Avgerinos, K.I.; Spyrou, N.; Bougioukas, K.I.; Kapogiannis, D. Effects of creatine supplementation on cognitive function of healthy individuals: A systematic review of randomized controlled trials. Exp. Gerontol. 2018, 108, 166–173. [Google Scholar] [CrossRef]
  19. Walker, J.B. Creatine: Biosynthesis, regulation, and function. Adv. Enzymol. Relat. Areas Mol. Biol. 1979, 50, 177–242. [Google Scholar] [PubMed]
  20. Braissant, O.; Bachmann, C.; Henry, H. Expression and function of AGAT, GAMT and CT1 in the mammalian brain. Alzheimer’s Dis. 2007, 46, 67–81. [Google Scholar] [CrossRef]
  21. Solis, M.Y.; Painelli, V.D.S.; Artioli, G.G.; Roschel, H.; Otaduy, M.C.; Gualano, B. Brain creatine depletion in vegetarians? A cross-sectional 1H-magnetic resonance spectroscopy (1H-MRS) study. Br. J. Nutr. 2013, 111, 1272–1274. [Google Scholar] [CrossRef] [Green Version]
  22. Stockler-Ipsiroglu, S.; Van Karnebeek, C.D.M.; Longo, N.; Korenke, G.C.; Mercimek-Mahmutoglu, S.; Marquart, I.; Barshop, B.; Grolik, C.; Schlune, A.; Angle, B.; et al. Guanidinoacetate methyltransferase (GAMT) deficiency: Outcomes in 48 individuals and recommendations for diagnosis, treatment and monitoring. Mol. Genet. Metab. 2014, 111, 16–25. [Google Scholar] [CrossRef] [PubMed]
  23. Laakso, M.P.; Hiltunen, Y.; Könönen, M.; Kivipelto, M.; Koivisto, A.; Hallikainen, M.; Soininen, H. Decreased brain creatine levels in elderly apolipoprotein E epsilon 4 carriers. J. Neural Transm. 2003, 110, 267–275. [Google Scholar] [CrossRef] [PubMed]
  24. Solis, M.Y.; Artioli, G.G.; Otaduy, M.C.G.; Leite, C.D.C.; Arruda, W.; Veiga, R.R.; Gualano, B. Effect of age, diet, and tissue type on PCr response to creatine supplementation. J. Appl. Physiol. 2017, 123, 407–414. [Google Scholar] [CrossRef] [Green Version]
  25. Rawson, E.S.; Venezia, A.C. Use of creatine in the elderly and evidence for effects on cognitive function in young and old. Amino Acids 2011, 40, 1349–1362. [Google Scholar] [CrossRef] [PubMed]
  26. Kreider, R.B.; Kalman, D.S.; Antonio, J.; Ziegenfuss, T.N.; Wildman, R.; Collins, R.; Candow, D.G.; Kleiner, S.M.; Almada, A.L.; Lopez, H.L. International Society of Sports Nutrition position stand: Safety and efficacy of creatine supplementation in exercise, sport, and medicine. J. Int. Soc. Sports Nutr. 2017, 14, 1–18. [Google Scholar] [CrossRef] [PubMed]
  27. Dechent, P.; Pouwels, P.J.W.; Wilken, B.; Hanefeld, F.; Frahm, J. Increase of total creatine in human brain after oral supplementation of creatine-monohydrate. Am. J. Physiol. Content 1999, 277, R698–R704. [Google Scholar] [CrossRef]
  28. Merege-Filho, C.A.A.; Otaduy, M.C.G.; De Sá-Pinto, A.L.; De Oliveira, M.O.; Gonçalves, L.D.S.; Hayashi, A.P.T.; Roschel, H.; Pereira, R.M.R.; Silva, C.A.; Brucki, S.M.D.; et al. Does brain creatine content rely on exogenous creatine in healthy youth? A proof-of-principle study. Appl. Physiol. Nutr. Metab. 2017, 42, 128–134. [Google Scholar] [CrossRef] [PubMed]
  29. Béard, E.; Braissant, O. Synthesis and transport of creatine in the CNS: Importance for cerebral functions. J. Neurochem. 2010, 115, 297–313. [Google Scholar] [CrossRef] [Green Version]
  30. Wilkinson, I.D.; Mitchel, N.; Breivik, S.; Greenwood, P.; Griffiths, P.D.; Winter, E.M.; Van Beek, E.J.R. Effects of Creatine Supplementation on Cerebral White Matter in Competitive Sportsmen. Clin. J. Sport Med. 2006, 16, 63–67. [Google Scholar] [CrossRef]
  31. Ostojić, S.M.; Ostojić, J.; Drid, P.; Vraneš, M. Guanidinoacetic acid versus creatine for improved brain and muscle creatine levels: A superiority pilot trial in healthy men. Appl. Physiol. Nutr. Metab. 2016, 41, 1005–1007. [Google Scholar] [CrossRef]
  32. Tachikawa, M.; Hosoya, K.-I. Transport characteristics of guanidino compounds at the blood-brain barrier and blood-cerebrospinal fluid barrier: Relevance to neural disorders. Fluids Barriers CNS 2011, 8, 13. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Alves, C.R.R.; Filho, C.A.A.M.; Benatti, F.B.; Brucki, S.M.D.; Pereira, R.M.R.; Pinto, A.L.D.S.; Lima, F.R.; Roschel, H.; Gualano, B. Creatine Supplementation Associated or Not with Strength Training upon Emotional and Cognitive Measures in Older Women: A Randomized Double-Blind Study. PLoS ONE 2013, 8, e76301. [Google Scholar] [CrossRef] [Green Version]
  34. Rawson, E.S.; Lieberman, H.R.; Walsh, T.M.; Zuber, S.M.; Harhart, J.M.; Matthews, T.C. Creatine supplementation does not improve cognitive function in young adults. Physiol. Behav. 2008, 95, 130–134. [Google Scholar] [CrossRef] [PubMed]
  35. Hammett, S.T.; Wall, M.B.; Edwards, T.C.; Smith, A. Dietary supplementation of creatine monohydrate reduces the human fMRI BOLD signal. Neurosci. Lett. 2010, 479, 201–205. [Google Scholar] [CrossRef] [PubMed]
  36. Ling, J.; Kritikos, M.; Tiplady, B. Cognitive effects of creatine ethyl ester supplementation. Behav. Pharmacol. 2009, 20, 673–679. [Google Scholar] [CrossRef] [Green Version]
  37. McMorris, T.; Harris, R.; Howard, A.; Langridge, G.; Hall, B.; Corbett, J.; Dicks, M.; Hodgson, C. Creatine supplementation, sleep deprivation, cortisol, melatonin and behavior. Physiol. Behav. 2007, 90, 21–28. [Google Scholar] [CrossRef] [PubMed]
  38. McMorris, T.; Harris, R.C.; Swain, J.; Corbett, J.; Collard, K.; Dyson, R.J.; Dye, L.; Hodgson, C.; Draper, N. Effect of creatine supplementation and sleep deprivation, with mild exercise, on cognitive and psychomotor performance, mood state, and plasma concentrations of catecholamines and cortisol. Psychopharmacology 2006, 185, 93–103. [Google Scholar] [CrossRef] [PubMed]
  39. Rae, C.D.; Digney, A.L.; McEwan, S.R.; Bates, T.C. Oral creatine monohydrate supplementation improves brain performance: A double–blind, placebo–controlled, cross–over trial. Proc. R. Soc. B Biol. Sci. 2003, 270, 2147–2150. [Google Scholar] [CrossRef] [Green Version]
  40. Watanabe, A.; Kato, N.; Kato, T. Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation. Neurosci. Res. 2002, 42, 279–285. [Google Scholar] [CrossRef]
  41. Borchio, L.; Machek, S.B.; Machado, M. Supplemental creatine monohydrate loading improves cognitive function in experienced mountain bikers. J. Sports Med. Phys. Fit. 2020, 60, 1168–1170. [Google Scholar] [CrossRef]
  42. Cook, C.J.; Crewther, B.T.; Kilduff, L.P.; Drawer, S.; Gaviglio, C.M. Skill execution and sleep deprivation: Effects of acute caffeine or creatine supplementation—A randomized placebo-controlled trial. J. Int. Soc. Sports Nutr. 2011, 8, 2. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Smolarek, A.C.; McAnulty, S.R.; Ferreira, L.H.; Cordeiro, G.R.; Alessi, A.; Rebesco, D.B.; Honorato, I.C.; Laat, E.F.; Mascarenhas, L.P.; Souza-Junior, T.P. Effect of 16 Weeks of Strength Training and Creatine Supplementation on Strength and Cognition in Older Adults: A Pilot Study. J. Exerc. Physiol. Online 2020, 23, 88–94. [Google Scholar]
  44. Van Cutsem, J.; Roelands, B.; Pluym, B.; Tassignon, B.; Verschueren, J.O.; De Pauw, K.; Meeusen, R. Can Creatine Combat the Mental Fatigue-associated Decrease in Visuomotor Skills? Med. Sci. Sports Exerc. 2020, 52, 120–130. [Google Scholar] [CrossRef]
  45. Meeusen, R. Exercise, Nutrition and the Brain. Sports Med. 2014, 44, 47–56. [Google Scholar] [CrossRef] [Green Version]
  46. Cox, G.; Mujika, I.; Tumilty, D.; Burke, L. Acute Creatine Supplementation and Performance during a Field Test Simulating Match Play in Elite Female Soccer Players. Int. J. Sport Nutr. Exerc. Metab. 2002, 12, 33–46. [Google Scholar] [CrossRef]
  47. Mohebbi, H.; Rahnama, N.; Moghadassi, M.; Ranjbar, K. Effect of Creatine Supplementation on Sprint and Skill Performance in Young Soccer Players. Middle-East J. Sci. Res. 2012, 12, 397–401. [Google Scholar]
  48. Dean, P.J.A.; Arikan, G.; Opitz, B.; Sterr, A. Potential for use of creatine supplementation following mild traumatic brain injury. Concussion 2017, 2, CNC34. [Google Scholar] [CrossRef] [Green Version]
  49. Vagnozzi, R.; Signoretti, S.; Floris, R.; Marziali, S.; Manara, M.; Amorini, A.M.; Belli, A.; Di Pietro, V.; D’Urso, S.; Pastore, F.S.; et al. Decrease in N-Acetylaspartate Following Concussion May Be Coupled to Decrease in Creatine. J. Head Trauma Rehabil. 2013, 28, 284–292. [Google Scholar] [CrossRef] [Green Version]
  50. Alosco, M.L.; Tripodis, Y.; Rowland, B.; Chua, A.S.; Liao, H.; Martin, B.; Jarnagin, J.; Chaisson, C.E.; Pasternak, O.; Karmacharya, S.; et al. A magnetic resonance spectroscopy investigation in symptomatic former NFL players. Brain Imaging Behav. 2020, 14, 1419–1429. [Google Scholar] [CrossRef] [PubMed]
  51. Barrett, E.C.; McBurney, M.I.; Ciappio, E.D. Omega-3 fatty acid supplementation as a potential therapeutic aid for the recovery from mild traumatic brain injury/concussion. Adv. Nutr 2014, 5, 268–277. [Google Scholar] [CrossRef]
  52. Sullivan, P.G.; Geiger, J.D.; Mattson, M.P.; Scheff, S.W. Dietary supplement creatine protects against traumatic brain injury. Ann. Neurol. 2000, 48, 723–729. [Google Scholar] [CrossRef]
  53. Ipsiroglu, O.S.; Stromberger, C.; Ilas, J.; Höger, H.; Mühl, A.; Stöckler-Ipsiroglu, S. Changes of tissue creatine concentrations upon oral supplementation of creatine-monohydrate in various animal species. Life Sci. 2001, 69, 1805–1815. [Google Scholar] [CrossRef]
  54. Sakellaris, G.; Kotsiou, M.; Tamiolaki, M.; Kalostos, G.; Tsapaki, E.; Spanaki, M.; Spilioti, M.; Charissis, G.; Evangeliou, A. Prevention of Complications Related to Traumatic Brain Injury in Children and Adolescents with Creatine Administration: An Open Label Randomized Pilot Study. J. Trauma: Inj. Infect. Crit. Care 2006, 61, 322–329. [Google Scholar] [CrossRef]
  55. Sakellaris, G.; Nasis, G.; Kotsiou, M.; Tamiolaki, M.; Charissis, G.; Evangeliou, A. Prevention of traumatic headache, dizziness and fatigue with creatine administration. A pilot study. Acta Paediatr. 2007, 97, 31–34. [Google Scholar] [CrossRef] [PubMed]
  56. Gualano, B.; Painelli, V.D.S.; Roschel, H.; Lugaresi, R.; Dorea, E.; Artioli, G.G.; Lima, F.R.; Da Silva, M.E.R.; Cunha, M.R.; Seguro, A.C.; et al. Creatine supplementation does not impair kidney function in type 2 diabetic patients: A randomized, double-blind, placebo-controlled, clinical trial. Graefe’s Arch. Clin. Exp. Ophthalmol. 2010, 111, 749–756. [Google Scholar] [CrossRef]
  57. Gualano, B.; Ferreira, D.C.; Sapienza, M.T.; Seguro, A.C.; Lancha, A.H. Effect of Short-term High-Dose Creatine Supplementation on Measured GFR in a Young Man with a Single Kidney. Am. J. Kidney Dis. 2010, 55, e7–e9. [Google Scholar] [CrossRef] [PubMed]
  58. Gualano, B.; Ugrinowitsch, C.; Novaes, R.B.; Artioli, G.G.; Shimizu, M.H.; Seguro, A.C.; Harris, R.C.; Lancha, A.H. Effects of creatine supplementation on renal function: A randomized, double-blind, placebo-controlled clinical trial. Graefe’s Arch. Clin. Exp. Ophthalmol. 2008, 103, 33–40. [Google Scholar] [CrossRef]
  59. Hayashi, A.P.; Solis, M.Y.; Sapienza, M.T.; Otaduy, M.C.G.; de Sa Pinto, A.L.; Silva, C.A.; Sallum, A.M.E.; Pereira, R.M.R.; Gualano, B. Efficacy and safety of creatine supplementation in childhood-onset systemic lupus erythematosus: A randomized, double-blind, placebo-controlled, crossover trial. Lupus 2014, 23, 1500–1511. [Google Scholar] [CrossRef]
  60. Lugaresi, R.; Leme, M.; Painelli, V.D.S.; Murai, I.H.; Roschel, H.; Sapienza, M.T.; Lancha, A.H.J.; Gualano, B. Does long-term creatine supplementation impair kidney function in resistance-trained individuals consuming a high-protein diet? J. Int. Soc. Sports Nutr. 2013, 10, 26. [Google Scholar] [CrossRef] [Green Version]
  61. Neves, M.; Gualano, B.; Roschel, H.; Lima, F.R.; De Sá-Pinto, A.L.; Seguro, A.C.; Shimizu, M.H.; Sapienza, M.T.; Fuller, R.; Lancha, A.H.; et al. Effect of creatine supplementation on measured glomerular filtration rate in postmenopausal women. Appl. Physiol. Nutr. Metab. 2011, 36, 419–422. [Google Scholar] [CrossRef]
  62. Rawson, E.S.; Clarkson, P.M.; Tarnopolsky, M.A. Perspectives on Exertional Rhabdomyolysis. Sports Med. 2017, 47, 33–49. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  63. Solis, M.Y.; Hayashi, A.P.; Artioli, G.G.; Roschel, H.; Sapienza, M.T.; Otaduy, M.C.; De Sã Pinto, A.L.; Silva, C.A.; Sallum, A.M.E.; Pereira, R.M.R.; et al. Efficacy and safety of creatine supplementation in juvenile dermatomyositis: A randomized, double-blind, placebo-controlled crossover trial. Muscle Nerve 2015, 53, 58–66. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Dietary creatine is transported through the blood–brain barrier via a creatine transporter. Astrocytes cells can also endogenously produce creatine, which is taken up by the neurons expressing the creatine transporter. Cr: creatine; PCr: phosphocreatine; Gly: glycine; Arg: arginine; AGAT: L-ariginine: glycine amidinotransferase; GAA: guanidinoacetate; GAMT: guanidinoacetate methyltransferase, SAM: S-adenosylmethionine; CreaT: Cr transporter. Created with
Figure 1. Dietary creatine is transported through the blood–brain barrier via a creatine transporter. Astrocytes cells can also endogenously produce creatine, which is taken up by the neurons expressing the creatine transporter. Cr: creatine; PCr: phosphocreatine; Gly: glycine; Arg: arginine; AGAT: L-ariginine: glycine amidinotransferase; GAA: guanidinoacetate; GAMT: guanidinoacetate methyltransferase, SAM: S-adenosylmethionine; CreaT: Cr transporter. Created with
Nutrients 13 00586 g001
Table 1. Effects of creatine supplementation on cognitive performance.
Table 1. Effects of creatine supplementation on cognitive performance.
PopulationCreatine Supplementation ProtocolCognitive Tests (CT)
Outcomes (O)
Healthy older women20 g/day + 5 g/day for 24 weeksCT: Mini-mental state examination, stroop, trail making, digit span, delay recall test and the short version of the geriatric depression scale
O: No change
Alves et al. (2013) [33]
Semiprofessional, non-vegetarian, male mountain bikers 20 g/day for 7 daysCT: Simple and choice reaction time, differentiation task test, Eiksen flanker test and Corsi block test
O: Creatine increased performance in choice reaction time, Eiksen flanker test and Corsi block test.
Borchio et al. (2020) [41]
Healthy young women (vegetarian and meat-eaters)20 g/day for 5 daysCT: Word recall, simple and choice reaction time, rapid visual information processing and controlled oral word association test
O: Word recall test performance was reduced in meat-eater after creatine supplementation (within-group comparison). Post supplementation performance was higher in vegetarians than in meat-eaters.
Benton and Donohoe (2011) [15]
Professional male rugby players who were sleep-deprived (3–5 h)0.05 or 0.1 g/kg/bw for 1 dayCT: Rugby passing skill test
O: Sleep deprivation reduced passing accuracy and creatine reversed this effect (trend for greater effect with larger dose).
Cook et al. (2011) [42]
Healthy young adults20 g/day for 5 days + 5 g/day for 2 daysCT: Backward digit span test and ravens advanced progressive matrices.
O: Backward digit span performance was increased after creatine.
Hammett et al. (2010) [35]
Healthy young men and women5 g/day for 15 daysCT: Memory scanning, number-pair matching, sustained attention, arrow flankers and IQ test
O: Aspect of improvement was reported in all the cognitive tests performed in the creatine group.
Ling et al. (2009) [36]
Healthy young men and women who were sleep-deprived (24 h) 20 g/day for 7 daysCT: Random number generation, forward and backward recall, visual reaction time, static balance and mood state
O: Performance reduction was attenuated in the creatine group for random movement generation, choice reaction time, balance and mood.
McMorris et al. (2006) [38]
Healthy elderly men and women20 g/day for 7 daysCT: Random number generation, forward and backward recall and long-term memory tests
O: Forward number recall, forward and backward spatial recall and long-term memory performance were enhanced after creatine supplementation.
McMorris et al. (2007a) [16]
Healthy young men who were sleep-deprived (36 h)20 g/day for 7 daysCT: Random number generation, short-term number recall, visual reaction time, cognitive effort, dynamic balance test and mood state
O: Performance on the random number generation test was improved following creatine.
McMorris et al. (2007b) [37]
Healthy male and female children 0.3 g/kg/day for 7 daysCT: Stroop, Rey auditory verbal learning test, Raven progressive matrices and trail making test
O: No change
Merege-Filho et al. (2017) [28]
Vegan and vegetarian healthy male and female young adults5 g/day for 6 weeksCT: Ravens advanced progressive matrices and Wechsler auditory backward digit span task
O: Creatine improved performance on the Raven’s test and the backward digit span task.
Rae and Broer (2015) [17]
Healthy male and female young adults0.03 g/kg/day for 6 weeksCT: Automated neuropsychological assessment metrics
O: No change
Rawson et al. (2008) [34]
Male and female institutionalized older adults (with full physical and mental capacities preserved)5 g/day for 16 weeksCT: Montreal Cognitive Assessment (MoCA) questionnaire
O: Creatine (plus resistance training) improved MoCA scores.
Smolarek et al. (2020) [43]
Healthy male and female young adults exposed to experimental hypoxia20 g/day for 7 daysCT: Neuropsychological test comprising verbal and visual memory, finger tapping, symbol digit coding stroop test, test of shifting attention, continuous performance test, alertness and peripheral and corticomotor excitability
O: Creatine supplementation offset hypoxia-induced decrements in a number of cognitive tests.
Turner et al. (2015) [10]
Healthy male and female young adults exposed to mental fatigue (90 min Stoop task)20 g/day for 7 daysCT: Psychomotor performance (visuomotor task with Fitlight-hardware and software), strength endurance task, Flanker test, heart rate, blood glucose, success motivation and intrinsic motivation, mood, session ratings of perceived exertion and mental fatigue
O: Accuracy throughout the 90 min Stroop task and strength endurance (in the non-dominant hand) were improved with creatine. No other effects of creatine supplementation were observed.
Van Cutsem et al. (2020) [44]
Healthy male and female young adults8 g/day for 5 daysCT: Serial calculation task (Uchida-Kraeplin)
O: Both groups increased mean performance. Mental fatigue, assessed during the second half of the test, was increased in the creatine group only.
Watanabe et al. (2002) [40]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Roschel, H.; Gualano, B.; Ostojic, S.M.; Rawson, E.S. Creatine Supplementation and Brain Health. Nutrients 2021, 13, 586.

AMA Style

Roschel H, Gualano B, Ostojic SM, Rawson ES. Creatine Supplementation and Brain Health. Nutrients. 2021; 13(2):586.

Chicago/Turabian Style

Roschel, Hamilton, Bruno Gualano, Sergej M. Ostojic, and Eric S. Rawson. 2021. "Creatine Supplementation and Brain Health" Nutrients 13, no. 2: 586.

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop